Bromfenac NDC 72266-142

NDC codes

FDA NDC Directory

Product NDC (as listed)72266-142Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72266-0142Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72266-142-01	72266014201	1 BOTTLE, DROPPER in 1 CARTON (72266-142-01) / 1.7 mL in 1 BOTTLE, DROPPERMarketed from Jul 6, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Bromfenac
Generic name (nonproprietary): bromfenac
Active ingredients: Bromfenac sodium — .9 mg/mL
Dosage form: Solution/ drops
Route: Ophthalmic
Labeler: Fosun Pharma USA Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 211029
Marketing start: Jul 6, 2020
Listing expires: Dec 31, 2026
Other FDA classes: Non-Steroidal (Chemical structure)Cyclooxygenase Inhibitors (Mechanism)
Identifiers: Product ID 72266-142_35c115a5-695f-5709-e063-6394a90a02a0SPL ID 35c115a5-695f-5709-e063-6394a90a02a0SPL set ID a8f1d85a-5585-4632-bdfa-a54a535b5c17RxCUI 578018UNII 8ECV571Y37
Pharmacologic class: Nonsteroidal Anti-inflammatory Drug

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472266014201 followed by a unit qualifier and the quantity

Package 72266-0142-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 22, 2025.

Indications (excerpt from the label)

Bromfenac ophthalmic solution 0.09% is indicated for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract surgery. Bromfenac ophthalmic solution is a nonsteroidal anti-inflammatory drug (NSAID) indicated for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract extraction.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 211029

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 211029
Product	Strength	Form · route	Labeler	Product NDC
Bromfenac	Bromfenac sodium .9 mg/mL	Solution/ dropsOphthalmic	Gland Pharma Limited	68083-313